Distribution Services · Medical Distributors · NSE: VIVOBIOT · data 2026-10-09
Vivo Bio Tech Ltd.
Health check: Weak (0.9/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹14.93
Market cap
₹32 cr
P/E
—
P/B
—
ROE
-2.0%
ROCE
8.3%
Debt / equity
0.72
Dividend yield
0.00%
1-year return
-25.9%
52-week high
₹20.94
52-week low
₹12.8
Operating margin
17.2%
Growth
| Revenue (last 12 months) | ₹55 cr |
| Net profit (last 12 months) | ₹-3 cr |
| Sales growth, 3 years (yearly) | 0.7% |
| Profit growth, 3 years (yearly) | — |
Similar companies
QMS Medical Allied Services Limited (QMSMEDI) · Vijaypd Ceutical Limited (VIJAYPD) · Balaxi Pharmaceuticals Limited (BALAXI) · Aakaar Medical Technologies Limited (AAKAAR) · Mono Pharmacare Limited (MONOPHARMA)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open VIVOBIOT in NSE Scanner →